The Retatrutide Phase 2 trial (published 2023) enrolled 338 adults with BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity
It is an emergency antidote in treatment of poisoning by radiotherapy drugs and chemicals (chemotherapeutic drug, anti-tuberculosis drugs, neurolytics, antidepressants, analgesics and antipyretics)
Ashraf AJ, Jeandriens HG, Parkes PW, So
Over a decade of use, cumulative costs reach $800-2,400 CAD for generic products
BPC-157 Healing from the Inside Out BPC-157 (Body Protection Compound) is a peptide derived from gastric proteins and has been shown to support healing across multiple systems
doi: 10.3389/fnut.2025.1627949 Received 14 May 2025 Accepted 11 July 2025 Published 30 July 2025 Volume 12 - 2025 Edited by Hariprasath Lakshmanan, JSS Academy of Higher Education and Research, India Reviewed by Marisabel Mecca, Oncological Center of Basilicata (IRCCS), Italy Mohit Agrawal, K